**Core Concept**
The management of alcohol-induced hepatitis involves the use of medications that promote abstinence and prevent relapse. This requires a deep understanding of the pharmacological properties of various drugs and their effects on the central nervous system, particularly the GABAergic and dopaminergic systems.

**Why the Correct Answer is Right**
In the context of alcohol-induced hepatitis, relapse prevention often involves the use of medications such as naltrexone, acamprosate, and disulfiram. Naltrexone works by blocking the opioid receptors in the brain, thereby reducing the craving for alcohol. Acamprosate, on the other hand, stabilizes the chemical signaling in the brain that would otherwise be disrupted by alcohol withdrawal. Disulfiram, however, works by inhibiting the enzyme aldehyde dehydrogenase, which is involved in the breakdown of acetaldehyde, a toxic byproduct of alcohol metabolism. **This results in an unpleasant reaction when alcohol is consumed, thereby discouraging its use**.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a commonly used medication for relapse prevention in alcohol-induced hepatitis.
**Option B:** This option is incorrect because it is not a well-established treatment for alcohol-induced hepatitis and may even exacerbate the condition.
**Option C:** This option is incorrect because it is not a suitable choice for relapse prevention in this context, as it may not address the underlying issues of alcohol craving and dependence.

**Clinical Pearl / High-Yield Fact**
Acamprosate is a medication that can be used in conjunction with naltrexone for relapse prevention in patients with alcohol-induced hepatitis. However, it is essential to note that disulfiram should be avoided in patients with severe liver dysfunction, as it can exacerbate liver damage.

**Correct Answer:**
D.